Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Calithera Biosciences Inc CALA

Healthcare Biotechnology
Calithera Biosciences, Inc. is a shell company. The Company is winding up its operations. The Company is seeking to sell all of its clinical assets and programs. The Company has not generated any revenue.

Recent & Breaking News (GREY:CALA)

Calithera Biosciences, Inc. Announces Commencement of Underwritten Public Offering of Common Stock

GlobeNewswire April 15, 2020

Calithera Biosciences Provides Update on Business Operations

GlobeNewswire April 14, 2020

Calithera Biosciences Reports Fourth Quarter 2019 Financial Results and Recent Highlights

GlobeNewswire March 11, 2020

Calithera Biosciences to Report Fourth Quarter 2019 Financial Results on Wednesday, March 11, 2020

GlobeNewswire March 4, 2020

Calithera to Participate in the 9th Annual SVB Leerink Global Healthcare Conference

GlobeNewswire February 19, 2020

Calithera Biosciences Provides Overview of 2020 Corporate Milestones and Financial Guidance

GlobeNewswire January 13, 2020

Calithera Biosciences Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire January 3, 2020

Data from Investigator-Sponsored Phase 2 Study of Calithera's Telaglenastat with Azacitidine in Myelodysplastic Syndrome to be Presented at ASH Annual Meeting 2019

GlobeNewswire December 6, 2019

Calithera Biosciences Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire December 5, 2019

Calithera Biosciences Reports Third Quarter 2019 Financial Results and Recent Highlights

GlobeNewswire November 12, 2019

Calithera to Present Preclinical Data from IL4I1 and CD73 Programs at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire November 5, 2019

Calithera Biosciences to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019

GlobeNewswire November 4, 2019

Calithera Biosciences Completes Patient Enrollment in Randomized CANTATA Trial of Telaglenastat and Cabozantinib in Advanced Renal Cell Carcinoma

GlobeNewswire October 3, 2019

Calithera Announces Acceptance of Two Abstracts for Presentation at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire October 1, 2019

New Data Presented at ESMO Congress 2019 from the Arginase Inhibitor INCB001158 Alone and in Combination with Pembrolizumab

GlobeNewswire September 29, 2019

Data From Randomized Phase 2 ENTRATA Study Demonstrate Telaglenastat with Everolimus Improves Progression-Free Survival in Renal Cell Carcinoma

GlobeNewswire September 28, 2019

Calithera to Host Webcast Conference Call for Analysts and Investors During European Society for Medical Oncology (ESMO) Congress 2019

GlobeNewswire September 26, 2019

Calithera to Present at the 2019 Cantor Global Healthcare Conference

GlobeNewswire September 25, 2019

Calithera Biosciences to Present New Data on Two Oncology Programs at ESMO Congress 2019

GlobeNewswire September 3, 2019

Calithera to Participate in Wells Fargo Healthcare Conference and Citi 14th Annual Biotech Conference

GlobeNewswire August 28, 2019